日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語(yǔ)Fran?ais
Latest News

Pharmaceutical enterprises making innovation faster and more relevant

By He Wei in Shanghai | China Daily | Updated: 2020-07-23 11:43
Share
Share - WeChat
Visitors at the exhibition area of French pharmaceutical giant Sanofi during the second China International Import Expo in Shanghai on Nov 10, 2019. [Photo/Xinhua]

Global pharmaceutical enterprises are looking to boost business operations in China in a bid to make innovation faster and more relevant to the market.

Business executives attribute the upbeat prospects in China to a thriving digital landscape, strong on-the-ground demand for innovation as well as government efforts to cut red tape and encourage technological breakthroughs.

In July, German science and technology conglomerate Merck opened its M Lab Collaboration Center in Shanghai-an in-house facility that fosters new drug development and offers customized solutions from services to training.

Albeit being the ninth such hub worldwide, the one-stop, technology and training center houses 13 labs and claims to be the biggest of its kind for Merck. It boasts four new functionalities including supporting food and beverage security-related inspections as well as environmental industries that are exclusive to the China market.

"The M Lab means faster turnaround, lowered costs as no travel out of China is needed, access to a vast network of biologics and bio-development experts within Merck and enhanced customer convenience," said Steve Vermant, managing director of Merck Life Science China.

For instance, in a dedicated research lab into proteins-the fundamental building block of life sciences-the company provides solutions from protein preparation and analysis to a number of relevant research tools. These stand to provide customers in China with hands-on training and support them on method optimization and application extension.

The existing global network of M Labs has reaped gains across the value chain during the ongoing COVID-19 pandemic, said Ian Carmichael, vice-president and head of bio processing at Merck Life Science China.

"Some of the candidates for drugs or vaccines have been able to accelerate to commercialization because of the work that was done between Merck and the customers in the past. We can go from labs to clinical trials," Carmichael said.

1 2 Next   >>|

Today's Top News

Editor's picks

Most Viewed

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 蜜桃久久| 麻豆影视在线 | 久久天天| 亚洲欧美日韩国产精品26u | 亚洲色域网 | 日本三级韩国三级香港三级 | 久久综合伊人 | 日韩一二三区 | 天天影院免费看电影 | 国产亚洲第一伦理第一区 | 国产成人综合日韩精品婷婷九月 | 777久久婷婷成人综合色 | 久久婷婷综合五月一区二区 | 九热精品 | 91精品欧美成人 | 五月婷婷丁香在线观看 | 精品国产一区二区三区成人影院 | 免费在线看a | 亚洲最大在线 | 成人国产精品免费 | 日本在线播放一区二区 | 中文字幕精品一区久久久久 | 婷婷在线网| 在线播放一区二区三区 | 欧美亚洲视频 | 性夜影院爽黄e爽在线观看 苏晓晖个人简介军衔 | 91在线 | 欧美 | 女人午夜色又刺激黄的视频免费 | www.久草.com | 亚洲第一区视频在线观看 | 免费污视频 | 五月天激情综合网 | 日韩一区二区中文字幕 | 国产欧美日韩亚洲精品区2345 | 一区免费看 | 免费特黄一级欧美大片在线看 | 97国产精品| 天天夜夜骑 | 免费看a | a一级爱做片免费 | 亚洲综合精品一区二区三区中文 |